Different Effects of Propranolol, Bisoprolol, Carvedilol and Doxazosin on Heart Rate, Blood Pressure, and Plasma Concentrations of Epinephrine and Norepinephrine

Journal of Clinical and Basic Cardiology

Volumn 6, Issue 1-4, 2003, Pages 69-72

  Stoschitzky, Kurt ^a,b   Koshucharova, G ^a   Zweiker, R ^a   Lercher, P ^a   Maier, R ^a   Watzinger, N ^a   Kraxner, W ^a   Klein, W ^a   Donnerer, J ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY HOSPITAL GRAZ   (Austria)

Author keywords

Alpha blockade; Beta blockade; Sympathetic drive; Sympathicus

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DOXAZOSIN; MELATONIN; NORADRENALIN; PROPRANOLOL;

ADRENALIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SELECTIVITY; EXERCISE; HEART HEMODYNAMICS; HEART RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INCIDENCE; MALE; NORADRENALIN BLOOD LEVEL; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYMPATHETIC TONE;

EID: 0347384159     PISSN: 15612775     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Cruickshank JM, Prichard BNC. Beta-blockers in clinical practice. Churchill Livingston, Edinburgh, 1994.
2. Cowen PJ, Bevan JS, Gosden B, Elliott SA. Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration. Br J Clin Pharmacol 1985; 19: 258-60.
3. Stoschitzky K, Sakotnik A, Lercher P, Zweiker R, Maier R, Liebmann P, Lindner W. Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol 1999; 55: 111-5.
4. Gilbert EM, Abraham WT, Olsen S, Hattler B, White M, Mealy P, Larrabee P, Bristow MR. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation 1996; 94: 2817-25.
5. Stoschitzky K, Koshucharova G, Lercher P, Maier R, Sakotnik A, Klein W, Liebmann PM, Lindner W. Stereoselective effects of (R)- and (S)-carvedilol in humans. Chirality 2001; 13: 342-6.
6. Koshucharova G, Zweiker R, Maier R, Lercher P, Stepan V, Klein W, Stoschitzky K. Different beta-blocking effects of carvedilol and bisoprolol in humans. J Clin Basic Cardiol 2001; 4: 53-6.
7. Stoschitzky K, Koshucharova G, Zweiker R, Maier R, Watzinger N, Fruhwald FM, Klein W. Differing beta-blocking effects of carvedilol and metoprolol. Eur J Heart Failure 2001; 3: 343-9.
8. Stoschitzky K, Klein W, Lindner W. Time to reassess chiral aspects of β-adrenoceptor antagonists. Trends Pharmacol Sci 1997; 18: 306-7.
9. Stoschitzky K, Zernig G, Lindner W. Racemic beta-blockers - fixed combinations of different drugs. J Clin Basic Cardiol 1998; 1: 14-8.
10. Donnerer J. Reflex activation of the adrenal medulla during hypoglycemia and circulatory dysregulations is regulated by capsaicin-sensitive afferents. Naunyn-Schmiedebergs Arch Pharmacol 1988; 338: 282-6.
11. Yoshikawa T, Port JD, Asano K, Chidiak P, Bouvier M, Dutcher D, Roden RL, Minobe W, Tremmel KD, Bristow MR. Cardiac adrenergic receptor effects of carvedilol. Eur Heart J 1996; 17 (Suppl B): 8-16.
12. Bristow MR. Mechanism of action of beta-blocking agents in heart failure. Am J Cardiol 1997; 80 (Suppl): 26L-40L.
13. Maack C, Cremers B, Flesch M, Höper A, Südkamp M, Böhm M. Different intrinsic activities of bucindolol, carvedilol and metoprolol in human failing myocardium. Br J Pharmacol 2000; 130: 1131-9.
14. Bristow MR. β-adrenergic receptor blockade in chronic heart failure. Circulation 2000; 101: 558-69.